Conditions: Kidney Transplant; Chronic Kidney Disease
Interventions: Drug: Empagliflozin
Sponsors: VA Office of Research and Development; Iowa City VA Health Care System; VA Pittsburgh Healthcare System; VA Tennessee Valley Health Care System; VA Hines Health Care
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
